HRA Pharma has launched the emergency oral contraceptive ellaOne (ulipristal acetate) in South Korea through its licensee for this market, Hyundai Pharm.
The prescription-only product is a successor to HRA's levonorgestrel-only emergency OC NorLevo, which has been available in South Korea for nearly 10 years, also through Hyundai. The older product is...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?